Trauma Devices – Market Insights – Asia Pacific

Growth in the Asia Pacific trauma device market will be supported by favorable demographics and rising adoption of innovative devices. However, several factors will dampen growth, such as the Chinese government’s volume-based procurement policy, which is placing downward pressure on ASPs in the country. In general, downward pricing pressures in various trauma device segments will partially offset the positive impact of procedure expansion and unit sales on revenues.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the Asia Pacific region from 2019 to 2033.

The implementation of volume-based procurement in China has impacted the overall trauma device market.

How has this government initiative affected the trauma device market in China?

What aspects of the initiative have helped drive growth potential in the trauma device space?

How has volume-based procurement affected MNCs versus local competitors?

MNCs remain the leading competitors in the market, but domestic competitors continue to capture share.

What strategies have MNCs leveraged to maintain their shares and remain competitive?

Which local competitors have been able to capture notable shares within the Asia Pacific trauma device space, and what strategies have they used to successfully generate sales?

China and India will see faster trauma device procedure growth compared to Australia and South Korea.

What factors have supported procedure volumes in the Chinese and Indian trauma device market?

What trends are being seen in the more mature Australian and South Korean markets for trauma devices?

How has reimbursement affected purchasing preferences in the region, and how will that evolve over the forecast period?